Epidemiology of Disappearing Plasmodium vivax Malaria: A Case Study in Rural Amazonia
Carregando...
Citações na Scopus
78
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
BARBOSA, Susana
GOZZE, Amanda B.
LIMA, Nathalia F.
BATISTA, Camilla L.
BASTOS, Melissa da Silva
NICOLETE, Vanessa C.
FONTOURA, Pablo S.
GONCALVES, Raquel M.
VIANA, Susana Ariane S.
MENEZES, Maria Jose
Citação
PLOS NEGLECTED TROPICAL DISEASES, v.8, n.8, article ID e3109, 13p, 2014
Resumo
Background: New frontier settlements across the Amazon Basin pose a major challenge for malaria elimination in Brazil. Here we describe the epidemiology of malaria during the early phases of occupation of farming settlements in Remansinho area, Brazilian Amazonia. We examine the relative contribution of low-density and asymptomatic parasitemias to the overall Plasmodium vivax burden over a period of declining transmission and discuss potential hurdles for malaria elimination in Remansinho and similar settings. Methods: Eight community-wide cross-sectional surveys, involving 584 subjects, were carried out in Remansinho over 3 years and complemented by active and passive surveillance of febrile illnesses between the surveys. We used quantitative PCR to detect low-density asexual parasitemias and gametocytemias missed by conventional microscopy. Mixed-effects multiple logistic regression models were used to characterize independent risk factors for P. vivax infection and disease. Principal Findings/Conclusions: P. vivax prevalence decreased from 23.8% (March-April 2010) to 3.0% (April-May 2013), with no P. falciparum infections diagnosed after March-April 2011. Although migrants from malaria-free areas were at increased risk of malaria, their odds of having P. vivax infection and disease decreased by 2-3% with each year of residence in Amazonia. Several findings indicate that low-density and asymptomatic P. vivax parasitemias may complicate residual malaria elimination in Remansinho: (a) the proportion of subpatent infections (i. e. missed by microscopy) increased from 43.8% to 73.1% as P. vivax transmission declined; (b) most (56.6%) P. vivax infections were asymptomatic and 32.8% of them were both subpatent and asymptomatic; (c) asymptomatic parasite carriers accounted for 54.4% of the total P. vivax biomass in the host population; (d) over 90% subpatent and asymptomatic P. vivax had PCR-detectable gametocytemias; and (e) few (17.0%) asymptomatic and subpatent P. vivax infections that were left untreated progressed to clinical disease over 6 weeks of follow-up and became detectable by routine malaria surveillance.
Palavras-chave
Referências
- Aguas R, 2008, PLOS ONE, V3, pe1767
- Alexander N, 2005, AM J TROP MED HYG, V73, P140
- Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
- Bereczky S, 2007, MICROBES INFECT, V9, P103, DOI 10.1016/j.micinf.2006.10.014
- Beurskens M, 2009, AM J TROP MED HYG, V81, P366
- Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27
- MARCELO L, 1994, AM J TROP MED HYG, V51, P16
- Camargo LMA, 1996, AM J TROP MED HYG, V55, P32
- Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/PNAS.0510576103
- Confalonieri UEC, 2014, ACTA TROP, V129, P33, DOI 10.1016/j.actatropica.2013.09.013
- da Silva NS, 2010, T ROY SOC TROP MED H, V104, P343, DOI 10.1016/j.trstmh.2009.12.010
- da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624
- da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001
- da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341
- Douglas NM, 2013, J INFECT DIS, V208, P801, DOI 10.1093/infdis/jit261
- Felger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045542
- Hahn MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085725
- KLEIN TA, 1990, J AM MOSQUITO CONTR, V6, P700
- Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452
- Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]
- LOURENCODEOLIVEIRA R, 1989, MEM I OSWALDO CRUZ, V84, P501
- Magris M, 2007, TROP MED INT HEALTH, V12, P392, DOI 10.1111/j.1365-3156.2006.01801.x
- Males S, 2008, CLIN INFECT DIS, V46, P516, DOI 10.1086/526529
- MARQUES AC, 1987, PARASITOL TODAY, V3, P166
- McKenzie FE, 2006, J PARASITOL, V92, P1281, DOI 10.1645/GE-911R.1
- Njama-Meya D, 2004, TROP MED INT HEALTH, V9, P862, DOI 10.1111/j.1365-3156.2004.01277.x
- Norris DE, 2004, ECOHEALTH, V1, P19, DOI 10.1007/s10393-004-0008-7
- Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
- Parker BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-178
- PERIGNON JL, 1994, MEM I OSWALDO CRUZ, V89, P51
- Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368
- Prata A, 1988, Rev Soc Bras Med Trop, V21, P51
- Roshanravan B, 2003, AM J TROP MED HYG, V69, P45
- Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001
- SAWYER D, 1993, SOC SCI MED, V37, P1131, DOI 10.1016/0277-9536(93)90252-Y
- Scopel KKG, 2004, ACTA TROP, V90, P61, DOI 10.1016/j.actratropica.2003.11.002
- Shanks GD, 2012, ADV PARASIT, V80, P301, DOI 10.1016/B978-0-12-397900-1.00006-2
- Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72
- Stresman G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-353
- Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467
- TADEI WP, 1988, REV I MED TROP, V30, P221
- Vittor AY, 2009, AM J TROP MED HYG, V81, P5
- Vittor AY, 2006, AM J TROP MED HYG, V74, P3
- Wampfler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076316
- WHO, 2013, WORLD MALARIA REPORT 2013, P1
- World Health Organization, 2012, DIS SURV MAL EL OP M
- Zimmerman R H, 1997, Rev Panam Salud Publica, V2, P18, DOI 10.1590/S1020-49891997000700004